The effect of thromboxane inhibition on vulnerability to ventricular fibrillation in the acute and chronic feline infarction models
- 1 April 1989
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 117 (4) , 848-853
- https://doi.org/10.1016/0002-8703(89)90622-4
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Thromboxane synthetase inhibition reduces ventricular irritability after coronary occlusion and reperfusionAmerican Heart Journal, 1988
- Reduction in myocardial neutrophil accumulation and infarct size following administration of thromboxane inhibitor U-63,557AAmerican Heart Journal, 1987
- Role of antithrombotic therapy in unstable angina, myocardial infarction and sudden deathJournal of the American College of Cardiology, 1986
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Development of an experimental model of acute myocardial infarction and the effects of a thromboxane synthetase inhibitor (OKY-046)American Heart Journal, 1986
- Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusionAmerican Heart Journal, 1986
- Antithrombotic Agents in Coronary Artery DiseaseChest, 1986
- Influence of site of stimulation on measurement of ventricular vulnerability in the normal and ischemic feline heartThe American Journal of Cardiology, 1984
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- The effects of RO-22-4679, a thromboxane synthetase inhibitor, on ventricular fibrillation induced by coronary artery occlusion in conscious dogs.Circulation Research, 1983